From the Department of Physiology and Pharmacology (J.C., N.W., A.D.K.)
and Department of Neurology (J.C., T.A.T., A.D.K., N.M.B.), Tel Aviv Medical
Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Correspondence to Dr N.M. Bornstein, Department of Neurology, Tel Aviv Medical Center, 6 Weizmann St, Tel Aviv, Israel.
Background and Purpose—There is a
growing interest in the use of genetic markers in the differential
diagnosis of dementia. In the current study we examined the usefulness
of genetic risk factors for vascular disease as markers for vascular
dementia (VD).
Methods—The groups included 41 patients with VD, 49 patients with
dementia of the Alzheimer's type, and 40 age-matched control
subjects without dementia. These patients were genotyped for
vascular disease–associated polymorphisms in the genes coding for
methylenetetrahydrofolate reductase
(MTHFR), angiotensin-converting enzyme (ACE), factor V
Leiden (FVL), and a common genetic risk factor for AD, apolipoprotein E
Results—There was no significant association between ACE, MTHFR,
and FVL genotypes with VD whether compared with subjects with
AD or with control subjects. There was a higher frequency of APOE
Conclusions—VD is not associated with the genetic risk factors
for vascular disease examined in this study, indicating that the
pathogenesis of VD may differ from other vascular diseases.
© 1998 American Heart Association, Inc.
Original Contributions
ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer's Dementia
4 (APOE 4). 4
alleles in patients with AD (30%, P=0.016) and VD
(26%, P=0.07) compared with control subjects
(15%).
Key Words: angiotensin-converting enzymes • apolipoprotein E • dementia • factor V Leiden • methylenetetrahydrofolate reductase
This article has been cited by other articles:
 |
|
 |
|
  H. Deng, W. Le, and J. Jankovic Genetics of essential tremor Brain, June 1, 2007; 130(6): 1456 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rowan, C.M. Morris, S. Stephens, C. Ballard, H. Dickinson, H. Rao, B.K. Saxby, A.T. McLaren, R.N. Kalaria, and R.A. Kenny Impact of Hypertension and Apolipoprotein E4 on Poststroke Cognition in Subjects >75 Years of Age Stroke, September 1, 2005; 36(9): 1864 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Lehmann, M. Cortina-Borja, D. R. Warden, A. D. Smith, K. Sleegers, J. A. Prince, C. M. van Duijn, and P. G. Kehoe Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease Am. J. Epidemiol., August 15, 2005; 162(4): 305 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-L Gueant, G Anello, P Bosco, R-M Gueant-Rodriguez, A Romano, C Barone, P Gerard, and C Romano Homocysteine and related genetic polymorphisms in Down's syndrome IQ J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 706 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Ballard, C. M. Morris, H. Rao, J. T. O'Brien, R. Barber, S. Stephens, E. Rowan, A. Gibson, R. N. Kalaria, and R. A. Kenny APOE {epsilon}4 and cognitive decline in older stroke patients with early cognitive impairment Neurology, October 26, 2004; 63(8): 1399 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Elkins, V. C. Douglas, and S. C. Johnston Alzheimer disease risk and genetic variation in ACE: A meta-analysis Neurology, February 10, 2004; 62(3): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Engelborghs, B Dermaut, J Goeman, J Saerens, P Marien, B. Pickut, M Van den Broeck, S Serneels, M Cruts, C Van Broeckhoven, et al. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1148 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Kehoe, H. Katzov, L. Feuk, A. M. Bennet, B. Johansson, B. Wiman, U. d. Faire, N. J. Cairns, G. K. Wilcock, A. J. Brookes, et al. Haplotypes extending across ACE are associated with Alzheimer's disease Hum. Mol. Genet., April 15, 2003; 12(8): 859 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. McIlroy, K. B. Dynan, J. T. Lawson, C. C. Patterson, and A. P. Passmore Moderately Elevated Plasma Homocysteine, Methylenetetrahydrofolate Reductase Genotype, and Risk for Stroke, Vascular Dementia, and Alzheimer Disease in Northern Ireland Stroke, October 1, 2002; 33(10): 2351 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M Mattila, J. O Rinne, M. Röyttä, P. Laippala, T. Pietilä, H. Kalimo, T. Koivula, H. Frey, and T. Lehtimäki Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon 4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology J. Med. Genet., October 1, 2000; 37(10): 766 - 770. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Narain, A. Yip, T. Murphy, C. Brayne, D. Easton, J. G. Evans, J. Xuereb, N. Cairns, M. M Esiri, R. A Furlong, et al. The ACE gene and Alzheimer's disease susceptibility J. Med. Genet., September 1, 2000; 37(9): 695 - 697. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-H. Yoo, G.-D. Choi, and S.-S. Kang Pathogenicity of Thermolabile Methylenetetrahydrofolate Reductase for Vascular Dementia Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1921 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Farrer, T. Sherbatich, S. A. Keryanov, G. I. Korovaitseva, E. A. Rogaeva, S. Petruk, S. Premkumar, Y. Moliaka, Y. Q. Song, Y. Pei, et al. Association Between Angiotensin-Converting Enzyme and Alzheimer Disease Arch Neurol, February 1, 2000; 57(2): 210 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhu, L. Fratiglioni, Z. Guo, H. Basun, E. H. Corder, B. Winblad, and M. Viitanen Incidence of Dementia in Relation to Stroke and the Apolipoprotein E {epsilon}4 Allele in the Very Old : Findings From a Population-Based Longitudinal Study Stroke, January 1, 2000; 31(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Gussekloo, B T Heijmans, P E Slagboom, A M Lagaay, D L Knook, and R G J Westendorp Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85 J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 535 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bova, J. Chapman, C. Sylantiev, A. D. Korczyn, and N. M. Bornstein The A677V Methylenetetrahydrofolate Reductase Gene Polymorphism and Carotid Atherosclerosis Stroke, October 1, 1999; 30(10): 2180 - 2182. [Abstract] [Full Text] [PDF]
|
|